A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy
Abstract. Recent evidence is focusing on the presence of a hypercoagulable state with development of both venous and arterial thromboembolic complications in patients infected with SARS-CoV-2. The ongoing activation of coagulation related to the severity of the illness is further characterized by th...
Main Authors: | Nuray Kusadasi, Maaike Sikma, Albert Huisman, Jan Westerink, Coen Maas, Roger Schutgens |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2020-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000457 |
Similar Items
-
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
by: Nazzarena Labò, et al.
Published: (2020-06-01) -
Pathophysiological consequences of SARS CoV-2
by: Hadeel Hameed, et al.
Published: (2021-03-01) -
Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19
by: Getu S, et al.
Published: (2021-07-01) -
Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists
by: Abeer M. Al-Subaie
Published: (2021-01-01) -
Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients
by: Tales Lyra Oliveira, et al.
Published: (2020-12-01)